This year, the German Society for Biomaterials has been celebrating its 20th anniversary. Starting as a small initiative with about 20 founding members, it has now developed into a medium-scale society with almost 300 members from academia, industry and hospitals. Looking back, we notice how much has happened in these 20 years. We have learned to better understand and even to manipulate cells and tissues, both in the vicinity of an implant as well as a part of an implant. The biomaterials have changed over the years from a pure, passive material (i.e., a polymer, a metal or a ceramic) to systems which are increasingly bioactive, i.e., which actively participate in the processes occurring in the body. This is extremely promising, and many exciting results are presented each year at our annual meeting.
If we look at the clinical application, however, the situation has not changed as much. Most biomaterials which are used clinically have remained the same: endoprostheses and dental implants with metallic and ceramic components, orthopaedic screws, nails and plates, bone cements based on PMMA, bone substitution materials consisting of hydroxyapatite and scaffolds based on collagen and resorbable polymers. The limited number of biomaterials in clinical use is probably due to regulatory issues which necessitate extensive testing prior to the introduction of new materials into the clinics. It is a long way from the research lab to the patient's bedside.
Nevertheless, there are still many unsolved problems in clinical medicine and dentistry which can be addressed by modern biomaterials. Let us simply consider the treatment of osteoporotic bone, the replacement of large bone defects, the reconstruction of joint cartilage, or the development of stable biodegradable implants which do not require an operation for removal. All these points are addressed by researchers today, and it will require our joint effort to introduce new materials and techniques into the operating theatre for the benefit of the patients.
Fundamental research is the key to successfully address such open questions. This research is driven both by scientific curiosity and by clinical demands. It is based on knowledge from previous results, and for this we need to spread and share information about our experimental work. We are therefore very grateful that the editor and the publisher have decided to re-launch the journal BIOmaterialien under the new label BioNanoMaterials with a truly international focus. Our society has joined a strategic partnership with DeGruyter to use this journal as a means to spread the results of our research to the world. An enthusiastic Editorial Board is necessary to reach that goal, and the publisher has certainly appointed the right persons to fulfil this task.
This special issue comprises articles from different areas in current biomaterials science that are addressed by the members of our society. As guest editors, we are grateful to the scientific editors and the publisher of BioNanoMaterials for all their help during the preparation of this volume. Have fun reading it!
